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Abstract Chaperonins are large oligomers made up of two
superimposed rings, each enclosing a cavity used for the folding
of other proteins. Among the chaperonins, the eukaryotic cyto-
solic chaperonin CCT is the most complex, not only with regard
to its subunit composition but also with respect to its function,
still not well understood. Unlike the more well studied eubacte-
rial chaperonin GroEL, which binds any protein that presents
stretches of hydrophobic residues, CCT recognises in its sub-
strates speci¢c binding determinants and interacts with them
through particular combinations of CCT subunits. Folding
then occurs after the conformational changes induced in the
chaperonin upon nucleotide binding have occurred, through a
mechanism that, although still poorly de¢ned, clearly di¡ers
from the one established for GroEL. Although CCT seems to
be mainly involved in the folding of actin and tubulin, other
substrates involved in various cellular roles are beginning to
be characterised, including many WD40-repeat, 7-blade propel-
ler proteins. * 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Chaperonins are a ubiquitous family of proteins involved in
the assistance to the folding of other proteins [1^3]. Their
general structure is that of a large cylinder (800^1000 kDa)
formed from two rings placed back-to-back, and constituted
of V60 kDa proteins which possess weak ATPase activity.
The cavity enclosed by each ring has an important role in
protein folding, since it provides the unfolded polypeptide a
con¢ned environment, generated after the conformational
changes induced upon ATP binding, where folding proceeds.
The manner in which the unfolded protein is con¢ned depends
on the type of chaperonin.
1.1. Group I chaperonins
These are present in eubacteria and in the eukaryotic or-
ganelles of endosymbiotic origin (mitochondria and chloro-
plast) and are the most well characterised ones, thanks to
the structural and functional work carried out with the Esche-
richia coli chaperonin, GroEL [4^7]. This chaperonin, like
most members of this group, is composed of two homohepta-
meric rings. Each monomer is divided into three domains: the
equatorial domain, containing the ATP binding site and re-
sponsible of most of the inter- and intra-ring interactions; the
apical domain, containing the residues responsible for the
binding of the unfolded polypeptide; and the intermediate
domain, which connects the ¢rst two domains. GroEL works
in conjunction with a small heptamer termed cochaperonin
(GroES in E. coli) that caps the chaperonin cavity after the
structural rearrangements induced in GroEL upon ATP bind-
ing, and forces the release into the cavity of the unfolded
polypeptide, which was previously bound to the apical do-
mains.
1.2. Group II chaperonins
This group, found in archaeabacteria and in the cytosol of
eukaryotic organisms, although sharing very low sequence
homology with its eubacterial counterparts, is more heteroge-
neous regarding its structure and composition. The archaeal
chaperonins, usually named thermosomes, can be octameric
or nonameric and can be composed of 1^3 di¡erent proteins
[8,9]. Little is known about the mechanism and folding of
substrates by these chaperonins. However, the atomic struc-
ture of the Thermoplasma acidophilum chaperonin has been
obtained [10,11], and its two component subunits (K and L)
reveal the same three-domain arrangement originally de-
scribed in the GroEL monomer, with a conserved equatorial
domain but a less similar apical domain, the substrate binding
region. The major di¡erence resides however in an extra re-
gion located in the tip of the apical domain, which is not
present in the group I chaperonins [10]. This protrusion closes
the cavity after the structural rearrangements induced in the
chaperonin upon ATP binding, [1,9^15] and probably plays
the equivalent role of a cochaperonin, which seems absent in
the group II chaperonin system.
2. The eukaryotic cytosolic chaperonin CCT
2.1. Structure and subunit composition
The most di¡erent and complex of all group II chaperonins
is the eukaryotic cytosolic chaperonin CCT (Chaperonin Con-
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taining TCP-1; also termed TRiC) [1,8,9,16^18]. It is di¡erent
because, unlike all the other chaperonins characterised so far,
it seems to be involved in the assistance of the folding of only
a small set of proteins (see below). CCT is also complex be-
cause, although is built up like the other chaperonins by two
superimposed rings [12,15,19,20], each ring is constituted by
eight di¡erent, albeit homologous subunits (30% identity)
(CCTK, L, Q, N, O, j, R, a ; CCT1-CCT8 in yeast), whose
arrangement within the ring has been determined [21^23].
This unique structural composition seems to be the same in
all eukaryotic CCT. In all the organisms and tissues studied
each CCT subunit is encoded by an unique gene [18], with the
exception of mammalian testis, which contains a tissue-specif-
ic CCTj2 [24]. The overall structure of CCT has been deter-
mined at 25^30 AM resolution by cryoelectron microscopy
[12,15,19,20] and is very similar to other group II chaperonins
[11,13,14,25], a barrel-shaped cylinder with a diameter of
V150 AM and a height of V160 AM , with every subunit inter-
acting with only one subunit from the opposite ring [11,12],
di¡erently from the staggered interaction observed in group I
chaperonins [4,5]. Unfortunately, no high-resolution informa-
tion of the entire CCT assembly has so far been obtained.
The conformational changes induced in CCT upon ATP
binding are of di¡erent nature to those observed in GroEL
(Fig. 1A). In the eubacterial chaperonin nucleotide binding
generates small changes that allow binding of the cochaper-
onin, which in turns induces large rearrangements of the oli-
gomeric structure and the closure of the ring cavity [5,26^28]
but ATP binding to CCT (and to group II chaperonins in
general) generates large conformational changes in the apical
domains that close the ring cavity [11^15,29]. The sealing of
the cavity is performed by the extra region present in the tip
of the apical domain of group II chaperonins, which acts like
an iris [15].
2.2. Folding mechanism of CCT
Like other chaperonins, CCT clearly uses its large confor-
mational rearrangements generated upon ATP binding [14,27]
to assist in the folding of other proteins [14]. However, there
are some aspects in the mechanism of the cytosolic chaperonin
that are di¡erent to any other known chaperonin, and which
have to do with the interaction between the chaperonin and
the substrate, and with the folding mechanism itself. In the
case of GroEL, the interaction with the unfolded polypeptide
is non-speci¢c and occurs between the hydrophobic surface of
the apical domain of any given subunit(s) and the exposed
hydrophobic region(s) of the unfolded polypeptide [30^32].
In the case the eukaryotic chaperonin, the interaction with
its unfolded substrates, actin and tubulin, occurs between spe-
ci¢c CCT subunits [1,20] and the binding determinants of the
two cytoskeletal proteins [33^36]. The speci¢c nature of the
interaction between CCT and its substrates suggests the pres-
ence of charged residues in the regions of the apical domains
where the electron microscopy studies of CCT:substrate com-
plexes have located the substrate-binding regions [19,20]. The
atomic structure of the CCTQ apical domain [37] shows that
this is the case, and the same can be implied of the other CCT
subunits, after comparison of their apical domain sequences
with that of CCTQ.
Another di¡erence between the two chaperonins is the na-
ture of the folded state of the chaperonin-bound unfolded
polypeptide. Numerous studies have shown that GroEL rec-
ognises any kind of folding conformation of an unfolded
polypeptide as long as the latter exposes a certain set of hy-
drophobic residues [31]. However, the CCT-interacting con-
formations of actin and tubulin, although determined at low
resolution by cryoelectron microscopy, are compatible with a
quasi-folded state which both cytoskeletal proteins may have
attained before the interaction with the cytosolic chaperonin
[20,39].
Finally, a further important di¡erence between the folding
mechanism of GroEL and CCT lies in the interaction between
the substrate and the chaperonin after nucleotide binding. In
the case of GroEL, the conformational changes brought
about by ATP and GroES binding liberate the unfolded poly-
peptide into the chaperonin cavity (sealed upon GroES bind-
ing) where it is given a chance to fold. This is a passive folding
mechanism (although see [38]), very di¡erent to the active
mechanism de¢ned for CCT, where the movements of the
apical domains induced upon ATP binding seal the chapero-
nin cavity and force the change of the bound, open confor-
mations of actin and tubulin towards compact, quasi-native
(or native) structures that are not liberated into the CCT
cavity but remain bound to the chaperonin [15]. The circular,
closed structure of the ring is used in both chaperonins to
isolate the unfolded polypeptide from the all the other poly-
peptides in the cytoplasmic compartment, but the cytosolic
chaperonin seems to use the conformational changes that
seal the ring to force the folding of its substrates.
2.3. Allostery in CCT
In all chaperonins studied so far, ATP binding and hydro-
lysis is used for maintaining their functional cycle not only
through the conformational changes that induce the closure
and opening of the ring cavity, but also through changes in
the substrate-binding a⁄nity between the open, substrate-re-
ceptive conformation and the closed conformation. These
changes are governed by nested cooperativity that involves
intra-ring positive cooperativity and inter-ring negative coop-
erativity in ATP binding [39]. This behaviour is observed in
CCT, although kinetic di¡erences with respect to the type I
chaperonin GroEL has lead to the suggestion that there may
be di¡erences in the intrinsic a⁄nities for ATP among the
di¡erent subunits in a ring [40]. This is compatible with the
fact that the eight di¡erent subunits are arranged in a ¢xed
position [21] and with genetic experiments that show that
ATP-binding in CCT takes place in a hierarchical manner,
di¡erent from the concerted manner characterised for GroEL
[41].
2.4. The interaction of CCT with actin and tubulin
Actin and tubulin have been characterised as the major
folding substrates for folding by CCT. Both cytoskeletal pro-
teins require in vivo and in vitro the interaction with CCT
each to fold to their native states [42]. Electron microscopy
experiments have shown that actin and tubulin each interact
with CCT in a quasi-folded conformation, with the two topo-
logical domains of both cytoskeletal proteins separated by a
hinge with the nucleotide binding site placed in its vicinity
[20].
In the case of actin, the interaction of its two topological
domains occurs between two CCT subunits localised in a 1,4
arrangement (CCTN and CCTL or CCTN and CCTO) [19]. The
interaction between the two tubulin domains and CCT is
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more complex, with ¢ve CCT subunits involved in tubulin
binding also in two alternative modes of interaction (see
Fig. 1B) [20]. It is possible that CCT may have evolved
from a primitive chaperonin for the purpose of, among other
things, overcoming speci¢c kinetic barriers in the folding of
both cytoskeletal proteins (and perhaps other proteins)
through the stabilisation of open conformations. If so, it is
possible that the critical steps in actin and tubulin folding,
brought about by the conformational changes generated in
CCT upon ATP binding, may have to do with the correct
folding of their nucleotide binding site. In both cytoskeletal
proteins, most of the inter-domain bonds that hold secure
their native structures occur through the nucleotide binding
site. In the case of actin, unfolding experiments have revealed
that its native conformation depends on the degree to which
the nucleotide contributes to the connectivity between the two
domains of the protein [43]. In the case of tubulin, biochem-
ical experiments show that GTP binding occurs after the clo-
sure of the CCT cavity [15,44].
2.5. Other CCT substrates
Although a matter of dispute for some time, it seems clear
now that CCT interacts with a large number of proteins (9^
15% of newly synthesised proteins [45] ; for a comprehensive
review of the substrates cited below, see [18,46]). Besides the
already cited actin and tubulin, CCT has been found to inter-
act either in vitro or in vivo with other cytoskeletal proteins
such as the heavy meromyosin subunit (HMM), actin-related
proteins, co¢lin and actin-depolymerising factor-1. Additional
proteins, involved in various cellular processes have been
Fig. 1. A: A schematic model of the folding mechanism of GroEL and CCT. Both chaperonins cycle between an open, substrate-receptive con-
formation and a closed conformation. In GroEL, substrate recognition and binding is performed in the open conformation by a hydrophobic
region in the apical domain of any of the GroEL subunits, which recognises any kind of unfolded conformation, provided the denatured poly-
peptide exposes a set of hydrophobic residues. The closed conformation is generated upon ATP binding in the presence of the cochaperonin
GroES, and the unfolded polypeptide is liberated in the GroEL cavity, where folding may take place using the information encoded in its own
amino acid sequence. The polypeptide, folded or not, is liberated from the GroEL cavity after GroES release, which is induced upon ATP hy-
drolysis and nucleotide liberation. In CCT, the apical domains of speci¢c subunits recognise a substrate conformation (at least, in the case of
actin and tubulin) that has acquired an important degree of secondary and tertiary structure. The sealing of the CCT, cavity carried out by the
movements of the apical domains induced upon ATP binding, is performed by the helical protrusions present at the tip of the apical domains,
and the substrate is not liberated in the CCT cavity but remains bound to the apical domains and forced to acquire a more compact, native
conformation. B: The actin and tubulin molecules, already in a quasi-native conformation, interact with the nucleotide-free, open conformation
of CCT through speci¢c subunits [20]. The N-terminal domains of actin and tubulin are depicted in red, whereas the C-terminal domains are
coloured blue.
Fig. 2. A model of the interaction of CCT with a WD40 7-blade
propeller protein. This model only intends to show that the WD40
protein ¢ts within the chaperonin cavity. The atomic structure of
GL-transducin (PDB accession code 2TRC) has been used as a mod-
el of a WD40 seven-blade propeller protein, and the eukaryotic
chaperonin is represented by a top view of the three-dimensional re-
construction obtained by cryoelectron microscopy of the open, sub-
strate-receptive conformation of CCT [20]. Bar indicates 50 AM .
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shown to interact with CCT. Among those, GK-transducin,
(involved in retinal phototransduction), cyclin E (implicated
in cell cycle control), and luciferase. Other proteins that are
folded by CCT are certain viral proteins such as the Epstein^
Barr virus-encoded nuclear protein (EBNA-3), the hepatitis B
virus capsid and the type D retrovirus Gag polyprotein. It is
puzzling that CCT retains the ability to interact so speci¢cally
with actin and tubulin and with this host of other non-homol-
ogous substrates.
Another CCT-interacting protein is the Von Hippel-Lindau
tumour suppressor protein (VHL) [47], which is associated
with renal cell cancer. VHL, complexed with elongins B and
C, forms part of the VCB^Cul2 complex, involved, like other
E3 ubiquitin ligase complexes, in protein degradation process-
es. CCT has been shown to bind VHL, pending its transfer to
the elongin BC complex [47,50]. VHL plays the role in the
VBC^Cul2 complex of a protein adapter, linking the complex
to its degradation substrate, much like the modular SOCS-box
proteins that form part of other E3 ubiquitin ligase complexes
[49]. VHL and the SOCS-box proteins contain two domains,
an E3 ubiquitin ligase binding site and a target substrate bind-
ing site. CCT binds to VHL at this second site, which in many
of the SOCS-box proteins contains WD40 repeats [50]. Curi-
ously enough, a proteomic analysis of Saccharomyces cerevi-
siae, using tagged open-reading frames to pull-down multi-
protein complexes has revealed a group of at least 21 proteins
that interact with the CCT oligomer (Table 1). These proteins
are involved in various cellular processes and a large percent-
age (16 proteins) have in common to posses in their sequence
7 WD40 motifs (Fig. 2) [51]. A hidden Markov model
(HMM) search of the WD40 repeat domain, as de¢ned in
the Pfam database (http://www.sanger.ac.uk/Software/Pfam),
through all S. cerevisiae proteins found 97 positive results,
containing between three and eight WD40 domains each,
thus these CCT-interacting ones represent 17% of the total
number of WD40 proteins in yeast. Most of these proteins
have molecular masses ranging from 55 to 100 kDa, and some
of them are therefore unlikely to be folded within the CCT
cavity. It is possible that CCT may a have a di¡erent role than
folding assistance with regard to these proteins; for example
regulating their activity by controlling their liberation into the
cytosol or binding to other proteins in assembly as with
VHL^celongin C^elongin B complex formation [48].
2.6. The interaction of CCT with other molecular chaperones
It seems now evident that many molecular chaperones work
in conjunction to orchestrate the folding process of di¡erent
proteins. In the case of CCT, prefoldin (PFD, also termed
GimC) [52,53] is a chaperone present in archaea and eukarya
that can be formally considered as a cochaperonin since it
physically interacts with CCT (see [54] and references therein).
The heterohexameric structure of PFD resembles that of a
jelly¢sh [55], using its tentacles to protect the nascent chain
from unwanted interactions and to transfer the unfolded poly-
peptide to CCT for its subsequent folding. In the case of the
eukaryotic PFD, only a few substrates have been character-
ised (actin, tubulin and VHL). Other chaperones seem to play
a role speci¢cally in the tubulin folding process after its inter-
action with CCT. K- and L-tubulin, once released from CCT,
interact respectively with cofactors B and A and are subse-
quently transferred with the help of cofactor C, to cofactors D
and E, respectively [55,56]. This complex process results in the
formation of stable K,L-dimers that can be incorporated into
the proto¢laments for microtubule formation. Finally, CCT
has been shown to interact with Hsp70, either directly [47] or
through the interaction with the Hsp70/Hsp90 organising pro-
tein (Hop, also termed p60) [57], thus linking CCT with two
other major chaperone systems, the Hsp90 system and the one
constituted by Hsp70/Hsp40.
2.7. Evolution of CCT
Gene duplication seems to be the driving force behind chap-
Table 1
Other CCT-interacting proteins found in the S. cerevisiae genomea
Gene nameb SwissProt codec Protein name/functiond WD40 Mw (kDa)e
CAF4/YKR036C YK16_YEAST Component of CCR4 transcriptional complex yes 74.7
CDC20/YGL116W CC20_YEAST Cell division control protein 20 yes 67.4
CDC55/YGL190C 2ABA_YEAST Protein phosphatase PP2A regulatory subunit B yes 59.7
CDH1/YGL003C YGA3_YEAST CDC20 homologue 1 yes 62.8
KSS1/YGR040W KSS1_YEAST Mitogen-activated protein kinase KSS1 no 42.7
PEX7/YDR142C PEX7_YEAST Peroxisomal targeting signal 2 receptor yes 42.3
PFS2/YNL317W YN57_YEAST Polyadenylation Factor I subunit 2 yes 53.1
PPH3/YDR075W P2A3_YEAST Protein phosphatase type 2A no 35.3
PRP46/YPL151C PR46_YEAST Pre-mRNA splicing factor PRP46 yes 50.7
PWP1/YLR196W PWP1_YEAST Periodic tryptophan protein 1 yes 63.8
RAD24/YER173W RA24_YEAST Checkpoint protein. Cell cycle exonuclease (putative) no 75.7
RAD28/YDR030C Q12021 Protein involved in the same pathway as Rad26p yes 58.2
SEC27/YGL137W COPP_YEAST Coatomer betaP subunit yes 99.4
SOF1/YLL011W SOF1_YEAST U3 snoRNP protein yes 56.8
STE4/YOR212W GBB_YEAST Guanine nucleotide-binding protein beta subunit yes 46.6
TAF90/YBR198C T2D4_YEAST Transcription initiation factor TFIID 90 kDa subunit yes 89.0
UTP7/KRE31/YER082C YER2_YEAST U3 snoRNP protein yes 62.3
WTM1/YOR230W WTM1_YEAST Transcriptional modulator WTM1 yes 48.4
YBL049W YBE9_YEAST Unknown no 16.1
YDL156W Q12510 Unknown yes 59.2
YJU2/YKL095W YKJ5_YEAST Unknown no 32.3
aThe proteins described in this table are those that in [51] have been found to interact with three or more CCT subunits.
bAccording to the ‘Saccharomyces Genome Database (SGD)’ ORF names (http://genome-www. stanford.edu/Saccharomyces).
cSwiss-Prot protein sequence database entry name (http://www.expasy.ch/sprot).
dFrom the Swiss-Prot ‘Protein name’ or the SGD ‘Gene Product’ or ‘Description’ database entry ¢elds.
eTheoretical molecular weight, calculated from the protein sequence composition, in kDa.
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eronin evolution [58], both in the simpler archaeal chaperonin
systems, composed of one to three di¡erent subunits and eu-
karyotic CCT, made up of its eight di¡erent subunits, prob-
ably explaining the more complex role of the eukaryotic chap-
eronin. The evolution of the group II chaperonins towards
heterooligomerisation is paralleled by that of their cochaper-
onin PFD, which in archaea is constituted by two K and four
L subunits (K and L being homologous) whereas in eukarya is
composed of six di¡erent subunits, two K-like and four L-like
subunits [54]. The appearance of the eight di¡erent subunits in
CCT occurred very early in eukaryotic evolution, at the same
time that a more complex cytoskeleton evolved to allow the
transition from prokaryotes to eukaryotes [18,59]. Actin and
tubulin form the core of the eukaryotic cytoskeleton and both
precisely require the assistance of CCT for their folding. The
domains of actin and tubulin putatively involved in CCT
binding are absent or greatly modi¢ed in their prokaryote
homologues FtsA/MreB and FtsZ, respectively, and most of
these domains are implicated in actin and tubulin polymeri-
sation function [60]. It is very likely that CCT evolved in the
eukarya kingdom as a direct consequence of the selective
pressure imposed by folding problems caused by the emergent
cytoskeletal proteins. The functional cycle was then probably
parasitised by other proteins to solve their own folding prob-
lems, and the cases of the viral proteins assisted in their fold-
ing by CCT are paradigmatic. Other CCT-interacting proteins
such as the ones containing WD40 motifs are very abundant
in eukaryotes and some may have used their interaction with
CCT for other purposes in addition to their own protein fold-
ing problems [50].
3. Concluding remarks
The biochemical and structural work carried out so far
points to CCT as a chaperonin which is very di¡erent from
the rest of the chaperonin family, not only in functional but
also in mechanistic terms. CCT is beginning to be character-
ised as a unique chaperone placed at the heart of cellular
control processes, assisting not only the folding of proteins
of critical importance but also controlling cellular pathways
such as cycle control of E3 ubiquitin ligases. Many interesting
issues remain to be addressed such as the comprehensive char-
acterisation of the conformational changes that govern the
CCT functional cycle and its interaction with the new sub-
strates that are beginning to be uncovered.
4. Note
We apologise for not citing many interesting papers found
in the literature owing to the limitations of space.
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